A significant debate unfolds over glyphosate, with the World Health Organization classifying it as a probable carcinogen. While some within the EPA express concerns, others believe the research supports its safety. This tension reveals how organizations like Monsanto leverage selective information to defend their products, highlighting the complexities of public health and regulatory decisions.
